repaglinide, a new oral hypoglycemic for type 2 diabetes
May 1998
You'll start to see ads for repaglinide, a new oralhypoglycemic for type 2 diabetes...from Novo Nordisk.
They're promoting it in the U.S. under the brand name, Prandin.But they'll probably use a different name in Canada...because"Prandin" is too similar to Prandase (acarbose).
Repaglinide is the first in a new class...the meglitinides.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive